Thus, the EPATH trial is the first clinical trial to specifically examine the effects of MR-blockade on PTH levels, bone, renal and CV health in patients with PTPH not undergoing surgery.
[25] However, two patients at short-term follow-up of 4 weeks revealed a similar decrease of PTH levels with MR-blockade compared to long-term follow-up, indicating a rapid effect of MR-blockade ...
A study published in the Journal of Clinical Endocrinology and Metabolism explores the relationship between weight loss, vitamin D status, | Cardiology ...
The associated bone diseases due to high parathyroid hormone (PTH) levels are managed with medications like Cinacalcet (Mimcipar), Bisphosphonates, and Denosumab--all of which are available in ...